Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.

计划入组 600 人 · 首次发布于 2024 年 9 月 24 日

Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China

计划入组 10 人 · 首次发布于 2013 年 9 月 2 日

Time Frame for GBS Screening

首次发布于 2019 年 10 月 4 日

GBS vaccine (Minervax)

IVT GBS-06 vaccine

IVT-GBS-6

THE ALBERT B. SABIN VACCINE INSTITUTE, INC.

United States

Hualan Biological Vaccine Inc.

China

AIM VACCINE

China

Inventprise's Novel COVID-19 Conjugate Vaccine Shows Broad Protection Against Multiple Variants in Preclinical Study

Pfizer's Hexavalent GBS Vaccine Clears Phase 1/2, But the Real Test Lies in Defining a Correlate of Protection

FDA Awards Breakthrough Status to Pfizer's Group B Strep Vaccine